[Lethal midline granuloma (LMG)].
Rolski
J
J
Kliniki Chemioterapii Oddziału Krakowskiego Centrum Onkologii Instytutu im M. Skłodowskiej-Curie.
Smolak
K
K
Gruchała
A
A
Drazek
R
R
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006103:Granuloma, Lethal Midline / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D009302:Nasopharyngeal Diseases / Q000175:diagnosis* / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage; D011879:Radiotherapy Dosage; D014750:Vincristine / Q000008:administration & dosage
D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
Lethal midline granuloma (LMG).